Genenta Science SpA ADR (GNTA)

Genenta Science SpA ADR (GNTA) is a Conglomerates company in the Industrials sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $34.8M; returns 1 day +0.0%, 1 week -6.7%, 1 year -80.5%.

Genenta Science S.p.A. (GNTA) is a clinical-stage biotechnology company based in Milan, Italy, that focuses on developing hematopoietic stem cell gene therapies for treating solid tumors. Their lead product candidate, Temferon, is in Phase 1/2a clinical trials for glioblastoma multiforme (GBM) with unmethylated MGMT gene promoter.

Groups GNTA belongs to

• Biotechnology
• Clinical Stage Biotech
• Gene Therapy
• Oncology
• Healthcare
• Cancer Therapeutics
• Life Sciences
• Biopharmaceutical
• Immunotherapy
• Clinical Stage
• Biologics

GNTA financial model: income statement, cash flow and balance sheet